Home The Word Brain	My Amedeo FAQ Privacy About
	C49 In our changing world, speaking just English isn't enough. Open new doors with skills in another world language. Start with 7 words a day. Next week: +49.

Gastric Cancer

Free Subscription Articles published in J Cancer Res Clin Oncol Retrieve available abstracts of 83 articles: HTML format

Single Articles

May 2025
1. CORSO G, Magnoni F, Bogani G, Veronesi P, et al
   Hereditary diffuse gastric and lobular breast cancer syndrome associated with germline CDH1 variants: focus on lobular breast cancer.
   J Cancer Res Clin Oncol. 2025;151:164.
   PubMed     Abstract available
   
   
   April 2025
2. XIA K, Zhou Y, Wang W, Cai Y, et al
   Streptococcus anginosus: the potential role in the progression of gastric cancer.
   J Cancer Res Clin Oncol. 2025;151:143.
   PubMed     Abstract available
   
   
   
3. CHENG G, Wusiman L, Song D, Zhang W, et al
   Silencing PPP2R1A inhibits the progression of gastric cancer cells.
   J Cancer Res Clin Oncol. 2025;151:142.
   PubMed     Abstract available
   
   
   March 2025
4. CHEN DH, Yu JW, Wu JG, Wang SL, et al
   Retraction Note: Significances of contactin?1 expression in human gastric cancer and knockdown of contactin?1 expression inhibits invasion and metastasis of MKN45 gastric cancer cells.
   J Cancer Res Clin Oncol. 2025;151:119.
   PubMed    
   
   
   
5. BOUNDER G, Jouimyi MR, Essaidi I, Elyounsi I, et al
   Upstream stimulating factor 1 (USF1) -202 G/A polymorphism and serum levels of USF1 and USF2 are associated with gastric cancer risk: a case control study.
   J Cancer Res Clin Oncol. 2025;151:113.
   PubMed     Abstract available
   
   
   February 2025
6. SHANG H, Feng T, Han D, Liang F, et al
   Deep learning and radiomics for gastric cancer serosal invasion: automated segmentation and multi-machine learning from two centers.
   J Cancer Res Clin Oncol. 2025;151:60.
   PubMed     Abstract available
   
   
   January 2025
7. ZHANG S, Su M, Li Q, Hu Q, et al
   Impact of (68)Ga-FAPI positron emission tomography/computed tomography on staging and tumor management in patients with gastric cancer.
   J Cancer Res Clin Oncol. 2025;151:35.
   PubMed     Abstract available
   
   
   December 2024
8. ZHOU L, Yang Y, Qiao Q, Mi Y, et al
   AKT1-Mediated NOTCH1 phosphorylation promotes gastric cancer progression via targeted regulation of IRS-1 transcription.
   J Cancer Res Clin Oncol. 2024;151:15.
   PubMed     Abstract available
   
   
   
9. YANG C, Wang S, Gao G, Xu P, et al
   RTEL1 is upregulated in gastric cancer and promotes tumor growth.
   J Cancer Res Clin Oncol. 2024;151:23.
   PubMed     Abstract available
   
   
   November 2024
10. IBRAHIM S, Maimaitiaili A, Zhu G, Ye S, et al
    Efficacy of sintilimab combined with neoadjuvant chemotherapy and trastuzumab in conversional treatment of locally advanced HER2-positive gastric cancer: case analysis and literature review.
    J Cancer Res Clin Oncol. 2024;150:507.
    PubMed     Abstract available
    
    
    October 2024
11. JOMRICH G, Yan W, Kollmann D, Kristo I, et al
    Elevated fibrinogen-albumin ratio is an adverse prognostic factor for patients with primarily resected gastroesophageal adenocarcinoma.
    J Cancer Res Clin Oncol. 2024;150:459.
    PubMed     Abstract available
    
    
    
12. ZHAO Z, Liu J, Gao X, Chen Z, et al
    SCYL1-mediated regulation of the mTORC1 signaling pathway inhibits autophagy and promotes gastric cancer metastasis.
    J Cancer Res Clin Oncol. 2024;150:456.
    PubMed     Abstract available
    
    
    September 2024
13. YANG X, Liu C, Li Z, Wen J, et al
    Paclitaxel hyperthermia suppresses gastric cancer migration through MiR-183-5p/PPP2CA/AKT/GSK3beta/beta-catenin axis.
    J Cancer Res Clin Oncol. 2024;150:416.
    PubMed     Abstract available
    
    
    August 2024
14. GE Y, Wang B, Xiao J, Wu H, et al
    NUSAP1 promotes gastric cancer radioresistance by inhibiting ubiquitination of ANXA2 and is suppressed by miR-129-5p.
    J Cancer Res Clin Oncol. 2024;150:406.
    PubMed     Abstract available
    
    
    
15. SHEN Y, Wu Y, Hao M, Fu M, et al
    Clinicopathological association of CD93 expression in gastric adenocarcinoma.
    J Cancer Res Clin Oncol. 2024;150:400.
    PubMed     Abstract available
    
    
    July 2024
16. CUI Z, Liang H, Luo R, Huang W, et al
    IKZF3 amplification predicts worse prognosis especially in intestinal-type gastric cancer.
    J Cancer Res Clin Oncol. 2024;150:363.
    PubMed     Abstract available
    
    
    
17. BALONOV I, Mattis M, Jarmusch S, Koletzko B, et al
    Metabolomic profiling of upper GI malignancies in blood and tissue: a systematic review and meta-analysis.
    J Cancer Res Clin Oncol. 2024;150:331.
    PubMed     Abstract available
    
    
    June 2024
18. LI Y, Zhou C, Wang G, Xin H, et al
    Identification and validation of the role of ZNF281 in 5-fluorouracil chemotherapy of gastric cancer.
    J Cancer Res Clin Oncol. 2024;150:307.
    PubMed     Abstract available
    
    
    
19. LIU X, Mao X, Zhu C, Liu H, et al
    COMMD10 inhibited DNA damage to promote the progression of gastric cancer.
    J Cancer Res Clin Oncol. 2024;150:305.
    PubMed     Abstract available
    
    
    May 2024
20. MAO C, Zhang Z, Fang R, Yuan W, et al
    A novel tRNA-derived fragment tRF-17-18VBY9M works as a potential diagnostic biomarker for gastric cancer.
    J Cancer Res Clin Oncol. 2024;150:263.
    PubMed     Abstract available
    
    
    
21. LIU T, Ma Y, Han S, Sun P, et al
    Genome-wide investigation of lncRNAs revealed their tight association with gastric cancer.
    J Cancer Res Clin Oncol. 2024;150:261.
    PubMed     Abstract available
    
    
    
22. LU Y, Wang H, Chen S, Yang B, et al
    Cystatin SA attenuates gastric cancer cells growth and increases sensitivity to oxaliplatin via PI3K/AKT signaling pathway.
    J Cancer Res Clin Oncol. 2024;150:244.
    PubMed     Abstract available
    
    
    
23. CHENG L, Li X, Dong W, Yang J, et al
    LAMC2 regulates the proliferation, invasion, and metastasis of gastric cancer via PI3K/Akt signaling pathway.
    J Cancer Res Clin Oncol. 2024;150:230.
    PubMed     Abstract available
    
    
    April 2024
24. WEI YY, Cai JY, Wang LL, Yang J, et al
    Dynamic change in the peritoneal cancer index based on CT after chemotherapy in the overall survival prediction of gastric cancer patients with peritoneal metastasis.
    J Cancer Res Clin Oncol. 2024;150:222.
    PubMed     Abstract available
    
    
    
25. ZHANG X, Wei Y, Wu F, Li M, et al
    UBE2L3 expression in human gastric cancer and its clinical significance.
    J Cancer Res Clin Oncol. 2024;150:210.
    PubMed     Abstract available
    
    
    
26. HAO W, Liu W, Chang R, Yang M, et al
    Safety and clinical efficacy of immune checkpoint inhibitors in advanced gastric cancer in the real world.
    J Cancer Res Clin Oncol. 2024;150:180.
    PubMed     Abstract available
    
    
    March 2024
27. PENG H, Wu X, Zhang C, Liang Y, et al
    Analyzing the associations between tertiary lymphoid structures and postoperative prognosis, along with immunotherapy response in gastric cancer: findings from pooled cohort studies.
    J Cancer Res Clin Oncol. 2024;150:153.
    PubMed     Abstract available
    
    
    
28. LI F, Wen Z
    Identification roles of NFE2L3 in digestive system cancers.
    J Cancer Res Clin Oncol. 2024;150:150.
    PubMed     Abstract available
    
    
    
29. WU W, Luo Z, Fang Y, Yu L, et al
    Preoperative ultrasound-guided dual localization with titanium clips and carbon nanoparticles for predicting the surgical approach and guiding the resection of Siewert type II esophagogastric junction adenocarcinoma.
    J Cancer Res Clin Oncol. 2024;150:145.
    PubMed     Abstract available
    
    
    February 2024
30. ZHAO W, Yao Z, Cao J, Liu Y, et al
    Helicobacter pylori upregulates circPGD and promotes development of gastric cancer.
    J Cancer Res Clin Oncol. 2024;150:104.
    PubMed     Abstract available
    
    
    
31. ZHANG C, Wang C, Mao G, Cheng G, et al
    Radiomics analysis of contrast-enhanced computerized tomography for differentiation of gastric schwannomas from gastric gastrointestinal stromal tumors.
    J Cancer Res Clin Oncol. 2024;150:87.
    PubMed     Abstract available
    
    
    January 2024
32. KRIEG S, Loosen S, Krieg A, Luedde T, et al
    Association between iron deficiency anemia and subsequent stomach and colorectal cancer diagnosis in Germany.
    J Cancer Res Clin Oncol. 2024;150:53.
    PubMed     Abstract available
    
    
    
33. LIN W, Zhu Z, Shang Y
    Gastroenteropancreatic neuroendocrine carcinoma in children and adolescents: a population-based study.
    J Cancer Res Clin Oncol. 2024;150:4.
    PubMed     Abstract available
    
    
    November 2023
34. GUO J, Deng Z, Jin L, Yin S, et al
    Prognostic value of hyperthermic intraperitoneal chemotherapy in gastric cancer with synchronous peritoneal metastases: a real-world retrospective study.
    J Cancer Res Clin Oncol. 2023 Nov 10. doi: 10.1007/s00432-023-05481.
    PubMed     Abstract available
    
    
    
35. LAI H, Zheng J, Zhou G, Li Y, et al
    Clinical characteristics and prognostic outcomes for adenocarcinoma of esophagogastric junction in early-onset patients: a population-based appraisal.
    J Cancer Res Clin Oncol. 2023;149:14941-14952.
    PubMed     Abstract available
    
    
    October 2023
36. KOHLRUSS M, Chakraborty S, Hapfelmeier A, Jesinghaus M, et al
    Low microsatellite instability: A distinct instability type in gastric cancer?
    J Cancer Res Clin Oncol. 2023 Oct 11. doi: 10.1007/s00432-023-05430.
    PubMed     Abstract available
    
    
    September 2023
37. CHEN S, Zhan S, Ding S, Zhang Q, et al
    B7-H3 and CD47 co-expression in gastric cancer is a predictor of poor prognosis and potential targets for future dual-targeting immunotherapy.
    J Cancer Res Clin Oncol. 2023 Sep 16. doi: 10.1007/s00432-023-05408.
    PubMed     Abstract available
    
    
    
38. ZHANG S, Zheng L, Zhang Y, Gao Y, et al
    A web-based prediction model for long-term cancer-specific survival of middle-aged patients with early-stage gastric cancer: a multi-institutional retrospective study.
    J Cancer Res Clin Oncol. 2023 Sep 15. doi: 10.1007/s00432-023-05405.
    PubMed     Abstract available
    
    
    
39. LEI X, Cui ZY, Huang XJ
    Exploration of gastric carcinogenesis from the relationship between bile acids and intestinal metaplasia and intragastric microorganisms (H. pylori and non-H. pylori).
    J Cancer Res Clin Oncol. 2023 Sep 14. doi: 10.1007/s00432-023-05407.
    PubMed     Abstract available
    
    
    
40. LIANG T, Cheng M, Lu L, Liu R, et al
    Competing endogenous RNA network characterization of lymph node metastases in Leuran gastric cancer subtypes.
    J Cancer Res Clin Oncol. 2023 Sep 9. doi: 10.1007/s00432-023-05382.
    PubMed     Abstract available
    
    
    
41. HUANG B, Ding F, Li Y
    A practical recurrence risk model based on Lasso-Cox regression for gastric cancer.
    J Cancer Res Clin Oncol. 2023 Sep 6. doi: 10.1007/s00432-023-05346.
    PubMed     Abstract available
    
    
    
42. SHITARA K, George B, Taieb J, Sundar R, et al
    Effects of prior therapies on outcomes with trifluridine/tipiracil in patients with metastatic gastric/gastroesophageal junction cancer in a randomized phase III trial (TAGS).
    J Cancer Res Clin Oncol. 2023;149:9361-9374.
    PubMed     Abstract available
    
    
    
43. NIE D, Zheng H, An G, Li J, et al
    Development and validation of a novel nomogram for postoperative overall survival of patients with primary gastric signet-ring cell carcinoma: a population study based on SEER database.
    J Cancer Res Clin Oncol. 2023;149:8593-8603.
    PubMed     Abstract available
    
    
    
44. WANG S, Chen C, Zhang J, Li J, et al
    Prognostic value of blood lipids on patients treated with oxaliplatin combined with S-1 (SOX) after radical gastrectomy and establishment of prognostic nomogram.
    J Cancer Res Clin Oncol. 2023;149:10293-10305.
    PubMed     Abstract available
    
    
    
45. SHEN Y, Li Y, Wang Z, Xu W, et al
    The prognostic value of FAR and a novel FAR-CA125 score in resectable gastric signet ring cell carcinoma patients.
    J Cancer Res Clin Oncol. 2023;149:9597-9608.
    PubMed     Abstract available
    
    
    August 2023
46. WEI C, Ma Y, Wang F, Chen Y, et al
    Machine learning and single-cell sequencing reveal the potential regulatory factors of mitochondrial autophagy in the progression of gastric cancer.
    J Cancer Res Clin Oncol. 2023 Aug 31. doi: 10.1007/s00432-023-05287.
    PubMed     Abstract available
    
    
    
47. LI J, Yang X, Wang X, Jiang Y, et al
    Predicting the prognosis of operable gastric cancer patients by dynamic changes in platelets before and after surgery: a retrospective cohort study.
    J Cancer Res Clin Oncol. 2023 Aug 29. doi: 10.1007/s00432-023-05334.
    PubMed     Abstract available
    
    
    
48. HUO C, Gu Y, Wang D, Zhang X, et al
    STAT1 suppresses the transcriptional activity of TRIM21 in gastric cancer.
    J Cancer Res Clin Oncol. 2023 Aug 28. doi: 10.1007/s00432-023-05307.
    PubMed     Abstract available
    
    
    
49. CORSO G, Comelli G, Veronesi P, Bianchi B, et al
    Germline CDH1 variants in hereditary diffuse gastric cancer syndrome with focus on younger women.
    J Cancer Res Clin Oncol. 2023 Aug 28. doi: 10.1007/s00432-023-05318.
    PubMed     Abstract available
    
    
    
50. GUO X, Wang Y, Zha L, Li H, et al
    DNA methylation-related lncRNAs predict prognosis and immunotherapy response in gastric cancer.
    J Cancer Res Clin Oncol. 2023 Aug 17. doi: 10.1007/s00432-023-05234.
    PubMed     Abstract available
    
    
    
51. WANG J, Yu X, Shi A, Xie L, et al
    Predictive value of (18)F-FDG PET/CT multi-metabolic parameters and tumor metabolic heterogeneity in the prognosis of gastric cancer.
    J Cancer Res Clin Oncol. 2023 Aug 12. doi: 10.1007/s00432-023-05246.
    PubMed     Abstract available
    
    
    
52. NAPPO F, Fornaro L, Pompella L, Catanese S, et al
    Pattern of recurrence and overall survival in esophagogastric cancer after perioperative FLOT and clinical outcomes in MSI-H population: the PROSECCO Study.
    J Cancer Res Clin Oncol. 2023;149:6601-6611.
    PubMed     Abstract available
    
    
    
53. LORDICK F, Thuss-Patience P, Bitzer M, Maurus D, et al
    Immunological effects and activity of multiple doses of zolbetuximab in combination with zoledronic acid and interleukin-2 in a phase 1 study in patients with advanced gastric and gastroesophageal junction cancer.
    J Cancer Res Clin Oncol. 2023;149:5937-5950.
    PubMed     Abstract available
    
    
    
54. PLUM PS, Pamuk A, Barutcu AG, Mallmann C, et al
    Two decades of gastric and gastroesophageal junction cancer surgery.
    J Cancer Res Clin Oncol. 2023;149:7679-7688.
    PubMed     Abstract available
    
    
    
55. ABDALLA TSA, Pieper L, Kist M, Thomaschewski M, et al
    Gastrointestinal stromal tumors of the upper GI tract: population-based analysis of epidemiology, treatment and outcome based on data from the German Clinical Cancer Registry Group.
    J Cancer Res Clin Oncol. 2023;149:7461-7469.
    PubMed     Abstract available
    
    
    
56. WEN Y, Wang Y, Huang Y, Liu Z, et al
    PLVAP protein expression correlated with microbial composition, clinicopathological features, and prognosis of patients with stomach adenocarcinoma.
    J Cancer Res Clin Oncol. 2023;149:7139-7153.
    PubMed     Abstract available
    
    
    
57. YANG H, Xiang C, Mou Y, Zhou X, et al
    The investigation of volatile organic compounds in diagnosing (early) esophageal squamous cell carcinoma and gastric adenocarcinoma.
    J Cancer Res Clin Oncol. 2023;149:7029-7041.
    PubMed     Abstract available
    
    
    July 2023
58. YANG X, Zhu Z, Liang T, Lei X, et al
    Comprehensive analysis of anoikis-related genes in prognosis and immune infiltration of gastric cancer based on bulk and single-cell RNA sequencing data.
    J Cancer Res Clin Oncol. 2023 Jul 21. doi: 10.1007/s00432-023-05157.
    PubMed     Abstract available
    
    
    
59. ZHU XD, Zhang LX, Luo PQ, Zhu H, et al
    Prognostic significance of post-preoperative tumor markers increments in patients with non-metastatic gastric cancer.
    J Cancer Res Clin Oncol. 2023 Jul 10. doi: 10.1007/s00432-023-05131.
    PubMed     Abstract available
    
    
    
60. XUE Y, Zhang H, Zheng Z, Liu X, et al
    Predictive performance of radiomics for peritoneal metastasis in patients with gastric cancer: a meta-analysis and radiomics quality assessment.
    J Cancer Res Clin Oncol. 2023 Jul 9. doi: 10.1007/s00432-023-05096.
    PubMed     Abstract available
    
    
    
61. SHEN K, Chen B, Gao W
    Integrated single-cell RNA sequencing analysis reveals a mesenchymal stem cell-associated signature for estimating prognosis and drug sensitivity in gastric cancer.
    J Cancer Res Clin Oncol. 2023 Jul 6. doi: 10.1007/s00432-023-05058.
    PubMed     Abstract available
    
    
    
62. YU P, Huang X, Huang L, Dai G, et al
    Hyperthermic intraperitoneal chemotherapy (HIPEC) plus systemic chemotherapy versus systemic chemotherapy alone in locally advanced gastric cancer after D2 radical resection: a randomized-controlled study.
    J Cancer Res Clin Oncol. 2023 Jul 1. doi: 10.1007/s00432-023-05019.
    PubMed     Abstract available
    
    
    
63. VALCARCEL S, Gallego J, Jimenez-Fonseca P, Diez M, et al
    Does HER2 status influence in the benefit of ramucirumab and paclitaxel as second line treatment of advanced gastro-esophageal adenocarcinoma? Data from the AGAMENON-SEOM registry.
    J Cancer Res Clin Oncol. 2023;149:4077-4089.
    PubMed     Abstract available
    
    
    
64. LI J, Chen Y, Zhang Y, Peng X, et al
    Clinical value and influencing factors of establishing stomach cancer organoids by endoscopic biopsy.
    J Cancer Res Clin Oncol. 2023;149:3803-3810.
    PubMed     Abstract available
    
    
    
65. HUEMER F, Hecht S, Scharinger B, Schlintl V, et al
    Body composition dynamics and impact on clinical outcome in gastric and gastro-esophageal junction cancer patients undergoing perioperative chemotherapy with the FLOT protocol.
    J Cancer Res Clin Oncol. 2023;149:3051-3064.
    PubMed     Abstract available
    
    
    
66. ALBIN J, Fahrig L, Siemanowski J, Rehkaemper J, et al
    FGFR2-amplified tumor clones are markedly heterogeneously distributed in carcinomas of the upper gastrointestinal tract.
    J Cancer Res Clin Oncol. 2023;149:5289-5300.
    PubMed     Abstract available
    
    
    
67. XU RH, Zhao XK, Song X, Lei LL, et al
    Survival influence of gender on 42,345 patients with gastric cardia adenocarcinoma.
    J Cancer Res Clin Oncol. 2023;149:5205-5217.
    PubMed     Abstract available
    
    
    
68. ROSERY V, Mika S, Schmid KW, Reis H, et al
    Identification of a new prognostic score for patients with high-grade metastatic GEP-NEN treated with palliative chemotherapy.
    J Cancer Res Clin Oncol. 2023;149:4315-4325.
    PubMed     Abstract available
    
    
    June 2023
69. GASPAR-FIGUEIREDO S, Allemann P, Borgstein ABJ, Joliat GR, et al
    Impact of positive microscopic resection margins (R1) after gastrectomy in diffuse-type gastric cancer.
    J Cancer Res Clin Oncol. 2023 Jun 21. doi: 10.1007/s00432-023-04981.
    PubMed     Abstract available
    
    
    
70. FENG L, Li G, Li D, Duan G, et al
    Cuproptosis-related gene SERPINE1 is a prognostic biomarker and correlated with immune infiltrates in gastric cancer.
    J Cancer Res Clin Oncol. 2023 Jun 15. doi: 10.1007/s00432-023-04900.
    PubMed     Abstract available
    
    
    
71. ULASE D, Behrens HM, Kruger S, Heckl SM, et al
    LAG3 in gastric cancer: it's complicated.
    J Cancer Res Clin Oncol. 2023 Jun 14. doi: 10.1007/s00432-023-04954.
    PubMed     Abstract available
    
    
    
72. SHEN H, Dang W, Su R, Zhang Z, et al
    Pretreatment lymphocyte-monocyte ratio (LMR) as a superior predictor of short-term progression outcomes in patients with gastric cancer receiving second- and later-line apatinib regimens.
    J Cancer Res Clin Oncol. 2023 Jun 12. doi: 10.1007/s00432-023-04976.
    PubMed     Abstract available
    
    
    
73. WANG L, Xiao K, Dong Z, Meng T, et al
    A novel copper-induced cell death-related lncRNA prognostic signature associated with immune infiltration and clinical value in gastric cancer.
    J Cancer Res Clin Oncol. 2023 Jun 8. doi: 10.1007/s00432-023-04916.
    PubMed     Abstract available
    
    
    
74. MONITTOLA F, Bianchi M, Nasoni MG, Luchetti F, et al
    Gastric cancer cell types display distinct proteasome/immunoproteasome patterns associated with migration and resistance to proteasome inhibitors.
    J Cancer Res Clin Oncol. 2023 Jun 1. doi: 10.1007/s00432-023-04948.
    PubMed     Abstract available
    
    
    May 2023
75. WANG YK, Lv XX, Wang ZQ, Zhou YM, et al
    The significance of the microlymphangiogenesis, microangiogenesis, and combined detection of programmed cell death-1 protein (PD-1)/ki67 in gastric cancer tissues.
    J Cancer Res Clin Oncol. 2023 May 13. doi: 10.1007/s00432-023-04709.
    PubMed     Abstract available
    
    
    
76. MOHRING C, Timotheou A, Manczak A, Sadeghlar F, et al
    Efficacy and tolerability of fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) in unselected patients with advanced gastric and gastroesophageal cancer: does age really matter?
    J Cancer Res Clin Oncol. 2023;149:1849-1862.
    PubMed     Abstract available
    
    
    April 2023
77. ZHAO X, Zhao R, Feng Y, Qiu Z, et al
    The roles EpCAM plays to enhance the malignancy of gastric cancer.
    J Cancer Res Clin Oncol. 2023 Apr 24. doi: 10.1007/s00432-023-04767.
    PubMed     Abstract available
    
    
    
78. ZHU Q, He P, Zheng C, Chen Z, et al
    Identification and evaluation of novel serum autoantibody biomarkers for early diagnosis of gastric cancer and precancerous lesion.
    J Cancer Res Clin Oncol. 2023 Apr 20. doi: 10.1007/s00432-023-04732.
    PubMed     Abstract available
    
    
    
79. APOSTOLIDIS L, Lang K, Sisic L, Busch E, et al
    Outcome and prognostic factors in patients undergoing salvage therapy for recurrent esophagogastric cancer after multimodal treatment.
    J Cancer Res Clin Oncol. 2023;149:1373-1382.
    PubMed     Abstract available
    
    
    March 2023
80. HILTNER T, Kohlruss M, Herz AL, Lorenzen S, et al
    Microsatellite instability and sex-specific differences of survival in gastric cancer after neoadjuvant chemotherapy without and with taxane: An observational study in real world patients.
    J Cancer Res Clin Oncol. 2023 Mar 31. doi: 10.1007/s00432-023-04691.
    PubMed     Abstract available
    
    
    
81. ZHANG YY, Li J, Li F, Xue S, et al
    Palmitic acid combined with gamma-interferon inhibits gastric cancer progression by modulating tumor-associated macrophages' polarization via the TLR4 pathway.
    J Cancer Res Clin Oncol. 2023 Mar 2. doi: 10.1007/s00432-023-04655.
    PubMed     Abstract available
    
    
    
82. DING L, Miao X, Jiang X, Chen L, et al
    Adverse outcomes and health-ecological influencing factors of preoperative frailty among elderly patients with gastric cancer.
    J Cancer Res Clin Oncol. 2023 Mar 2. doi: 10.1007/s00432-023-04651.
    PubMed     Abstract available
    
    
    
83. KLEO K, Jovanovic VM, Arndold A, Lehmann A, et al
    Response prediction in patients with gastric and esophagogastric adenocarcinoma under neoadjuvant chemotherapy using targeted gene expression analysis and next-generation sequencing in pre-therapeutic biopsies.
    J Cancer Res Clin Oncol. 2023;149:1049-1061.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Gastric Cancer is free of charge.